Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
small decrease » small increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
Showing 1,241 - 1,260 results of 13,400 for search '(( significant ((step decrease) OR (small decrease)) ) OR ( significantly increased decrease ))', query time: 0.59s Refine Results
  1. 1241
    IL-10 levels in tumor lysates post-treatment.

    IL-10 levels in tumor lysates post-treatment. by Hedieh Zargaran (21410233)

    Published 2025
    Save to List
    Saved in:
  2. 1242
    PRRSV enters MARC-145 cells via macropinocytosis and rottlerin blocks the macropinocytosis by decreasing actin polymerization.

    PRRSV enters MARC-145 cells via macropinocytosis and rottlerin blocks the macropinocytosis by decreasing actin polymerization. by Yeonglim Kang (21395261)

    Published 2025
    Save to List
    Saved in:
  3. 1243
    Inhibition of foam cell formation.

    Inhibition of foam cell formation. by Bruno Musetti (9527085)

    Published 2024
    Save to List
    Saved in:
  4. 1244
    Change in Watt’s Connectedness Scale, Subscales by Treatment Group.

    Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1245
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1246
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1247
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1248
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1249
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1250
    Study CONSORT diagram.

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1251
    Change in Demoralization Scale (DSII) by Treatment Group.

    Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1252
    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group.

    Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1253
    The complex interplay between SGLT-2is, RAAS, and glucose metabolism in type 2 diabetes mellitus patients.

    The complex interplay between SGLT-2is, RAAS, and glucose metabolism in type 2 diabetes mellitus patients. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1254
    Time Course of the RAAS.

    Time Course of the RAAS. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1255
    Effects of SGLT-2is during the time course.

    Effects of SGLT-2is during the time course. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1256
    Changes of physical and biochemical indicators from baseline and difference between DKD and non-DKD patients.

    Changes of physical and biochemical indicators from baseline and difference between DKD and non-DKD patients. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1257
    Baseline characteristics between DKD and non-DKD patients.

    Baseline characteristics between DKD and non-DKD patients. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1258
    Flow diagram of patient recruitment.

    Flow diagram of patient recruitment. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1259
    Spearman correlation analysis of the RAAS and glucose metabolism indicators before and after treatment in DKD and non-DKD patients.

    Spearman correlation analysis of the RAAS and glucose metabolism indicators before and after treatment in DKD and non-DKD patients. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1260
    Multiple linear regression analysis of the RAAS and glucose metabolism indicators before and after treatment in DKD and non-DKD patients.

    Multiple linear regression analysis of the RAAS and glucose metabolism indicators before and after treatment in DKD and non-DKD patients. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: